Provided by Tiger Fintech (Singapore) Pte. Ltd.

Binah Capital Group Inc

2.38
-0.0200-0.83%
Post-market: 2.410.0300+1.26%16:38 EDT
Volume:98.84K
Turnover:225.52K
Market Cap:39.51M
PE:-7.46
High:2.52
Open:2.40
Low:2.12
Close:2.40
Loading ...

Press Release: enGene Reports First Quarter 2025 Financial Results and Provides Business Update

Dow Jones
·
11 Mar

Liberty Global to Present at the NewStreet Research and BCG Future of Connectivity Leaders Conference

Business Wire
·
11 Mar

More Women Step Into Leadership Roles in Ultrawealthy Families -- Barrons.com

Dow Jones
·
11 Mar

MiB: Philipp Carlsson-Szlezak, Global Chief Economist for BCG

The Big Picture
·
08 Mar

Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions

GlobeNewswire
·
06 Mar

ImmunityBio Receives FDA RMAT Designation for ANKTIVA® and CAR-NK for the Reversal of Lymphopenia in Patients Receiving Standard-of-Care Chemotherapy/Radiotherapy and in Treatment of Multiply Relapsed Locally Advanced or Metastatic Pancreatic Cancer

Business Wire
·
28 Feb

Trump tariffs on North America hint at first stirrings of what’s to hit South-east Asia

businesstimes
·
26 Feb

Is Western Digital Corporation (WDC) the Best Performing Data Center Stock So Far In 2025?

Insider Monkey
·
26 Feb

Is Super Micro Computer, Inc. (SMCI) the Best Performing Data Center Stock So Far In 2025?

Insider Monkey
·
26 Feb

Is GDS Holdings Limited (GDS) the Best Performing Data Center Stock So Far In 2025?

Insider Monkey
·
26 Feb

Is VNET Group, Inc. (VNET) the Best Performing Data Center Stock So Far In 2025?

Insider Monkey
·
26 Feb

Is Seagate Technology Holdings plc (STX) the Best Performing Data Center Stock So Far In 2025?

Insider Monkey
·
26 Feb

Is Intel Corporation (INTC) the Best Performing Data Center Stock So Far In 2025?

Insider Monkey
·
26 Feb

Is Rackspace Technology, Inc. (RXT) the Best Performing Data Center Stock So Far In 2025?

Insider Monkey
·
26 Feb

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Business Wire
·
25 Feb

Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.

GlobeNewswire
·
21 Feb

ImmunityBio Gets FDA Authorization for Expanded Access to Recombinant BCG for Bladder Cancer Treatment

MT Newswires Live
·
19 Feb

Binah Capital Group Inc files to sell 21.33M shares of common stock for holders

TIPRANKS
·
15 Feb

MiB: Christine Phillpotts, Ariel Investments

The Big Picture
·
15 Feb

Pfizer Reports Strong Full-Year 2024 Results And Reaffirms 2025 Guidance

Business Wire
·
04 Feb